Company: RPTX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103764
Chunk: 46

Company: Repare Therapeutics Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 46
---
 out on December 31, 2024 and the remaining 75% installment to be paid out on May 31, 2025, subject to their continued employment through such date (or an earlier involuntary termination by the Company without cause). Health and Welfare and Retirement Benefits Our named executive officers are eligible to participate in benefits available generally to salaried employees, such as participation in our 401(k) Plan in the United States and our retirement plan in Canada, medical, dental, vision coverage, short-term disability insurance, long-term disability insurance, group life insurance, health spending account, paid time off, holiday, and the Employee Share Purchase Plan, in each case on the same basis as our other employees. 32

We offer our employees in the United States the ability to participate in a 401(k) plan and we offer our employees in Canada the ability to participate in a retirement plan. We make non-matching employer contributions into both of these plans on behalf of participants equal to 3% of their base salary up to statutorily prescribed maximums.

The compensation committee periodically reviews the levels of benefits provided to executive officers to ensure that they remain reasonable and consistent with its compensation philosophy. Our board of directors may elect to adopt qualified or nonqualified benefit plans in the future, if it determines that doing so is in our best interests.

#### Perquisites
We do not provide significant perquisites or personal benefits to our named executive officers.

#### Employment Agreements and Severance Benefits
We provide our named executive officers with certain severance protections in their employment agreements in order to attract and retain an appropriate caliber of talent for such positions. Our employment agreements with the named executive officers and the severance provisions set forth therein are summarized below under “—Employment Arrangements with our Named Executive Officers” and “—Potential Payments and Benefits upon Termination or Change in Control.” Our compensation committee intends to periodically review the level of the benefits in these agreements.

<div align='center'>33</div>

Clawback Policy Our board of directors has adopted an Incentive Compensation Recoupment Policy that is compliant with Exchange Act Rule 10D-1 and the applicable rules promulgated by Nasdaq. The policy applies to incentive-based compensation received by covered executive officers that was granted, earned or vested based wholly or in part upon the attainment of a financial reporting measure, including our stock price or total shareholder return. Under this policy, in the event that either our board of directors or a court, regulator or other legally authorized body determines